Siemens Healthcare Diagnostics, Inc.: Device Recall

Recall #Z-3063-2024 · 07/29/2024

Class II: Risk

Recall Details

Recall Number
Z-3063-2024
Classification
Class II
Product Type
Device
Recalling Firm
Siemens Healthcare Diagnostics, Inc.
Status
Ongoing
Date Initiated
07/29/2024
Location
Tarrytown, NY, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,164 units (229 US, 935 OUS)

Reason for Recall

The potential for biased quality control (QC) and patient results when using Atellica CH UCFP lot 130414 and ADVIA Chemistry UCFP lot 140 reagents.

Product Description

Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP); Siemens Material Number (SMN): 11097543

Distribution Pattern

Worldwide - US Nationwide distribution in the states of CA, FL, GA, IA, IL, KY, LA, MS, NJ, NY, NV, PA, TX, VA, PR and the countries of Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Canada, Chile, China, Columbia, Croatia, Cura¿ao, St Eus, Czech Republic, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, India, India, Ireland, Italy, Jordan, Kenya, Korea, Kuwait, Latvia, Malaysia, Mexico, Netherlands, New Zealand, Norway, Oman, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, South Africa, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, U.A.E., United Kingdom, Uruguay, Vatikancity.

Other Recalls by Siemens Healthcare Diagnostics, Inc.

View all recalls by Siemens Healthcare Diagnostics, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.